Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe

Major regulatory milestone achieved toward approval in the European Union; final decision from the European Commission expected in the first quarter of 2015.

Published
21 November 2014
From
AbbVie press release
Racial Disparities in the US Gay Male HIV Epidemic Appear Entrenched

Despite many efforts to fight racial disparities in HIV rates among men who have sex with men (MSM), black MSM will likely continue to have disproportionately high HIV rates for decades. A modeling analysis projects how varying rates of HIV testing and retention in HIV care would affect racial disparities between black and white MSM.

Published
21 November 2014
From
AIDSMeds
CDC Releases Audit of Shuttered AIDS Group NAPWA

The Petrelis Files blog looks at the CDC audit of the National Association of People With AIDS (NAPWA), which declared bankruptcy and closed in 2013.

Published
21 November 2014
From
Poz magazine news
UNAIDS reports that reaching Fast-Track Targets will avert nearly 28 million new HIV infections and end the AIDS epidemic as a global health threat by 2030

If the world does not rapidly scale up in the next five years, the epidemic is likely to spring back with a higher rate of new HIV infections than today, UNAIDS says.

Published
19 November 2014
From
UNAIDS
One in eight gay men in London has HIV, official figures show

One in eight gay men in London has HIV according to figures released today, which reveal the disease is three times more prevalent in the capital than the rest of the country.

Published
19 November 2014
From
Evening Standard
NHS asks Nice to delay ground-breaking hepatitis C drug

Nice is due to finish its final assessment of sofosbuvir in January. It is usual for them to give the NHS three months to find the money or put staff – if needed – in place. NHS England is thought to have asked them to delay this by six months.

Published
19 November 2014
From
Channel 4 News (blog)
Pharmaceutical Industry Doing More to Improve Access to Medicine in Developing Countries; Performance on Some Aspects Lags

The world's leading pharmaceutical companies are doing more to improve access to medicine in developing countries, with a raft of new initiatives, scale-ups and innovations over the last two years. However, the industry struggles to perform well in some practices that matter, according to the 2014 Access to Medicine Index, published Monday. GSK tops the Index for the fourth time. This is driven by robust performance across most areas, with several innovative practices. Novo Nordisk has made the most progress, improving in five of the seven areas the Index focuses on. This has resulted in a remarkable leap from 6th to 2nd place. Sanofi and Pfizer fell down the ranking most significantly.

Published
18 November 2014
From
Access to Medicine Index
The Guy Who Delivers HIV Medicine On His Bicycle

Sizwe Nzima was a high school student in Cape Town, South Africa, when he would pick up the medicine for his HIV-positive grandparents, who had difficulty traveling to the clinic themselves. Because of the long lines, Nzima usually waited hours and often made multiple trips to the clinic before and after school. So there he was, sitting on a hard wooden bench at the clinic one day about four years ago, when he had an idea: Why not start an HIV medicine delivery service?

Published
18 November 2014
From
NPR (blog)
South Africa to spend $2.2 billion on HIV drugs in next two years

South Africa plans to spend $2.2 billion over two years to buy HIV/AIDS drugs for public hospitals, a government minister said on Monday, as a study shows the prevalence of the virus is rising.

Published
18 November 2014
From
Reuters
Practical steps to eliminating hepatitis C: a consensus for London

The aim of this document is to reinforce the need for urgent leadership from the Department of Health, PHE and NHS England and concerted action from Local Authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (CCGs) and service providers to improve hepatitis C testing and treatment services in London for people with a history of using drugs – the group most affected by chronic hepatitis C – in order to find and treat significantly more people affected by the disease.

Published
17 November 2014
From
London Joint Working Group on Substance Use and Hepatitis C
← First12345...453Next →

Filter by country